US Capital Partners Provides $750,000 in Follow-On Financing for Advanced Health Sciences, Inc US Capital Partners, LLC has

structured and put in place additional financing fo r an innovative and expanding Florida-based health care research and technology group. San Francisco, CA, October 30, 2013 -- US Capital Partners, LLC has provided a $ 750,000 growth capital term loan for Advanced Health Sciences, Inc. ("AHS"), hea dquartered in West Palm Beach, FL. US Capital Partners is a private investment b ank that makes direct debt investments, participates in debt facilities, and arr anges equity placements for small to lower middle market companies. "We are delighted that US Capital Partners has successfully provided this growth capital financing for us," said Jeff Ramey, founder and CEO of AHS. "We returne d to US Capital Partners following the successful financing of our sister compan y, Ramard, Inc. This new growth capital financing will allow AHS to offer a rang e of new cutting-edge natural health care products, including a varicose vein pr oduct, a migraine product, a respiratory product for sufferers of asthma and chr onic obstructive pulmonary disease, and a digestive product to battle Celiac dis ease, Crohn s disease, and diverticulitis." "In December 2012, US Capital Partners successfully provided an accounts receiva ble and inventory line of credit scalable to $1 million for AHS's sister company , Ramard, Inc., an expanding developer of high-quality equine and canine nutrace utical health care products," said Jeffrey Sweeney, CEO and Managing Director at US Capital Partners. "Ramard's products are used by nine Olympics equestrian te ams around the world, as well as top Kentucky Derby Thoroughbreds. We are deligh ted now to have provided $750,000 in additional financing for the group." About Advanced Health Sciences, Inc.: AHS is a collaboration of experienced health care professionals and scientific s pecialists who are dedicated to developing innovative, next-generation products for specific targeted health concerns. The company's team of researchers, bioche mists, and molecular biologists are on the cutting edge of research and technolo gy to provide a focused approach to health and well-being. AHS products are manu factured in an FDA and cGMP (current Good Manufacturing Practices) facility in t he United States to ensure outstanding quality. About US Capital Partners, LLC: Since 1998, US Capital Partners (www.uscapitalpartners.net) has been providing p rompt, innovative, and reliable financing solutions including lending, equity fi nancing, and debt re-structuring to businesses across the United States and abro ad. US Capital Partners is a private investment bank, direct lender, co-lender, and lead financial arranger that specializes in asset-based debt for small to mi ddle market private and public companies. The company's innovative approach allo ws it to provide the best financing available, not only for companies in excelle nt financial condition, but also for companies that may have been refused credit by traditional lenders. To learn more about how your business can secure the funding it needs, email Jef frey Sweeney, CEO and Managing Director, at jsweeney@uscapitalpartners.net or ca ll (415) 889-1010. Contact: Hilary Adams US Capital Partners, LLC 555 Montgomery Street, Suite 1501 San Francisco, CA 94111 415-889-1010

james@englishwordfactory.com http://www.uscapitalpartners.net